Innoblative Designs
CHICAGO, IL · Founded 2013 · CIK 0001664268 · Medtech · Private
SIRA® RFA Electrosurgical Device — a radiofrequency ablation system for soft tissue treatment in breast cancer and other conditions
innoblative.com →- Grants
- $906K
- 2 awards
- Sector median: 1
- Raised
- $4.4M
- 3 Form D · May 2017
- 113 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 16 granted · 24 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,178,363 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Automated system for creating custom three-dimensional radiofrequency ablation lesion geometries in post-lumpectomy margin ablation breast cancer treatment | $225,000 | |
| Federal grant | National Science Foundation · Phase II · STTR Phase II: Automated system for creating custom three-dimensional radiofrequency ablation lesion geometries in post-lumpectomy margin ablation breast cancer treatment | $680,659 | |
| Private capital raised | Form D · SEC | $2,258,358 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 815 | NeuMoDx Molecular, Inc. | — | $55M |
| 816 | Soliton, Inc. | — | $15M |
| 817 | Nano Precision Medical, Inc. | — | $6.6M |
| 818 | Innoblative Designs | — | $4.4M |
| 819 | ESTABLISHMENT LABS HOLDINGS INC. | — | $56M |
| 820 | TrackX Technology, Inc. | — | $11M |
| 821 | Woven Orthopedic Technologies, LLC | — | $5.8M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Dianne BlancoDirector
- Arthur HoldenDirector
- Kelly LondyDirector · Executive Officer
- Matthew SteinmetzDirector
- Gintaras VaisnysDirector
- Tyler WankeDirector · Executive Officer
Patents
- System For Minimally Invasive Tissue Ablation And Sealinggranted
- Screen Sphere Tissue Ablation Devices And Methodsgranted
- Minimally Invasive Articulating Assembly Having Ablation Capabilitiesapplication
- Electrosurgical Tissue And Vessel Sealing Deviceapplication
- Minimally Invasive Articulating Assembly Having Ablation Capabilitiesgranted
- Electrosurgical Tissue And Vessel Sealing Devicegranted
- Tissue Ablation Devices And Methodsapplication
- Cavitary Tissue Ablationapplication
- Screen Sphere Tissue Ablation Devices And Methodsapplication
- Treatment Devices And Methodsgranted
- Screen Sphere Tissue Ablation Devices And Methodsgranted
- Tissue Ablation Systemapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.